HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Organics Are Church & Dwight's Latest Vitafusion, L'il Critter Line Extensions

Executive Summary

C&D's latest gummy additions are organic versions of its vitafusion women's and men's multivitamins and vitamins B-12 and D3 for adults and its L'il Critters children's multivitamin. Firm's marketing chief for the brands credits L'il Critters and vitafusion lines with "essentially igniting the gummy revolution in the US."

You may also be interested in...



Church & Dwight Expects 3.5% Growth In 2019 On Line Extensions, Price Increases

Church & Dwight estimates 3.5% organic sales growth in 2019 on innovations including Orajel Toothache Strips as well as organic gummy vitamins and "world’s first flossing toothbrush.” Reporting weaker-than-expected Q$ earnings, it plans to raise prices on more product categories in 2019.

Vitafusion Ads Aim To Bounce Gummy Competitors' Gains From Discounts

Church & Dwight introduces Vitafusion gummy vitamin ads to counter aggressive promotional discounting by competitors in the segment. The firm's domestic sales grew 9.7% in the third quarter on product launches and as digital sales soared 70%.

Church & Dwight More Avid About Consumer Health Growth

The Vitafusion adult vitamins and L'il Critters multivitamins, fiber and omega-3 supplements for children far surpassed overall category growth of about 8% in the quarter, says CEO James Craigie, citing Nielsen data. Net income for the firm’s latest quarter period grew more than 12% to nearly $108 million.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS148727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel